• 1
    Fuji, N., Tanaka, F., Yamashita, Y., Ashizawa, T., Chiba, S. and Nakano, H. (1997) UCE6, a new antitumor antibiotic with topoisomerase I-mediated DNA cleavage activity produced by actinomycetes: producing organism, fermentation, isolation and biological activity. Journal of Antibiotics 50 , 490495.
  • 2
    Gresham, R. and Inamine, E. (1986) Nutritional improvement of processes. In Manual of Industrial Microbiology and Biotechnology ed. Demain, A.L. and Solomon, N.A. pp. 41–48. Washington: American Society for Microbiology.
  • 3
    Gupte, S.V. (1991) The selective isolation of some of the rare actinomycetes with reference to antibiotic production. PhD (Microbiology) Thesis submitted to the University of Mumbai, India.
  • 4
    Gupte, M.D. (2000) Novel metabolites from microorganisms. PhD (Microbiology) Thesis submitted to the University of Mumbai, India.
  • 5
    Lowe, S.E., Gustavson, D.R., Meyers, D.S., Veitch, J.A., Forenza, S. and Kam, K.S. (1997) The effect of carbon source, temperature and aeration on the production of Ascosteroside, a novel antifungal agent, by Ascotricha amphitricha. Journal of Antibiotics 50 , 412417.
  • 6
    USP (1985) In The United States Pharmacopoeia 21st Revision. p. 752. Rockville, MD: United States Pharmacopoeial Convention, Inc.
  • 7
    Waksman, S.A. (1959) Isolation, identification, cultivation and preservation. In The Actinomycetes: Nature, Occurrence and Activities Vol. 1, ed. Waksman, S.A. pp. 17–28. Baltimore: Williams & Wilkins Co.